Alpha Cognition Inc. Other Receivables, Net, Current
Alpha Cognition Inc. (ACOG) had Other Receivables, Net, Current of $173.92 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Other Receivables, Net, Current
us-gaap:OtherReceivablesNetCurrent · last filed 2026-08-13
- 2026-06-30: Other Receivables, Net, Current $173.92K.
- 2026-03-31: Other Receivables, Net, Current $173.92K.
- 2025-12-31: Other Receivables, Net, Current $202.53K.
- 2025-09-30: Other Receivables, Net, Current $129.17K.
| Period end | Other Receivables, Net, Current |
|---|---|
| 2026-06-30 | $173.92K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $173.92K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $202.53K 10-Q · filed 2026-08-13 |
| 2025-09-30 | $129.17K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $140.27K 10-Q · filed 2025-08-14 |
| 2024-12-31 | $253.43K 10-K · filed 2026-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |